Cytogel Pharma

Funding and NIH signals

• SEC Form D raise Filed a Form D for an offering of up to $16M, no sales reported yet (filed Dec 23, 2025; amended Mar 26, 2026). SEC Form D 0001213900-25-124742 (Dec 23, 2025)
  Evidence (1 event)

  • Dec 23, 2025 · SEC Form D 0001213900-25-124742
    Name of Issuer: Cytogel Pharma, LLC; CIK: 1491841; Address: Darien, CT; Submission type: D; Filing date: 2025-12-23; Industry Group: Pharmaceuticals; Date of First Sale: Yet to Occur; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 16000000; Total Amount Sold: 0; Federal exemptions: 06b || Name of Issuer: Cytogel Pharma, LLC; CIK: 1491841; Address: Darien, CT; Submission type: D/A; Filing date: 2025-12-23; Industry Group: Pharmaceuticals; Date of First Sale: 2025-10-14; Types of Securities Offered: Debt, Option/warrant; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 250000; Federal exemptions: 06b || Name of Issuer: Cytogel Pharma, LLC; CIK: 1491841; Address: Darien, CT; Submission type: D/A; Filing date: 2026-03-26; Industry Group: Pharmaceuticals; Date of First Sale: Yet to Occur; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 16000000; Total Amount Sold: 0; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals